dichlorphenamide has been researched along with Hyperpotassemia in 2 studies
Dichlorphenamide: A carbonic anhydrase inhibitor that is used in the treatment of glaucoma.
diclofenamide : A sulfonamide that is benzene-1,3-disulfonamide in which the hydrogens at positions 4 and 5 are substituted by chlorine. An oral carbonic anhydrase inhibitor, it partially suppresses the secretion (inflow) of aqueous humor in the eye and so reduces intraocular pressure. It is used for the treatment of glaucoma.
Excerpt | Relevance | Reference |
---|---|---|
"Oral dichlorphenamide (Keveyis™) is a carbonic anhydrase inhibitor that is approved in the USA for the treatment of primary hyperkalaemic and hypokalaemic periodic paralyses and related variants." | 2.53 | Dichlorphenamide: A Review in Primary Periodic Paralyses. ( Greig, SL, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Greig, SL | 1 |
Wakabayashi, Y | 1 |
1 review available for dichlorphenamide and Hyperpotassemia
Article | Year |
---|---|
Dichlorphenamide: A Review in Primary Periodic Paralyses.
Topics: Carbonic Anhydrase Inhibitors; Clinical Trials, Phase III as Topic; Cross-Over Studies; Dichlorphena | 2016 |
1 other study available for dichlorphenamide and Hyperpotassemia
Article | Year |
---|---|
Hyperkalaemia induced by carbonic anhydrase inhibitor.
Topics: Acidosis; Acute Kidney Injury; Aged; Aged, 80 and over; Aldosterone; Dichlorphenamide; Glaucoma; Hum | 1991 |